Sorted By:

Relevance


Programs and Initiatives

PhRMA  |  From PhRMA

Explore the interactive map below and select a state to access data on biopharmaceutical jobs, the industry's overall economic impact, clinical trial activity, and more. 
https://www.phrma.org/resources/state-map/stem

PhRMA Announces Dr. Richard Moscicki as New Chief Medical Officer and Executive Vice President

PhRMA  |  Press Release

Moscicki received his medical degree from Northwestern University Medical School and is board certified in internal medicine, diagnostic and laboratory immunology, and allergy and immunology.
https://www.phrma.org

PhRMA letter to Puerto Rico Secretary of Economic Development and Commerce

PhRMA  |  Press Release

Thank you for your consideration and support of these objectives and please do not hesitate to contact us with any questions or comments.
https://www.phrma.org/press-release/phrma-letter-to-puerto-rico-secretary-of-economic-development-and-commerce

Driving Innovation and Economic Growth for the 21st Century

PhRMA  |  Report

This report details the continuing rise of state policies and programs to attract, retain, and grow an innovative biopharmaceutical presence.
https://www.phrma.org

More Than 200 Innovative Medicines in Development For Heart Disease and Stroke

PhRMA  |  Press Release

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research and biotechnology companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives.
https://www.phrma.org/press-release/more-than-200-innovative-medicines-in-development-for-heart-disease-and-stroke

PhRMA Comment: Draft Guidance for Industry and Review Staff: Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities

PhRMA  |  Speeches & Communication

The Pharmaceutical Research and Manufacturers of America's comments in response to FDA’s Draft Guidance for Industry and Review Staff entitled “Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities/Questions and Answers”. – Questions and Answers, Docket No.
https://www.phrma.org

PhRMA Statement on the Sunshine Act and the Public Release of the Open Payments Database

PhRMA  |  Press Release

 Sunshine Act and Open Payments Database Letters -         PhRMA, AdvaMed and BIO Letter to CMS -         Physician and Industry Groups Call on CMS to Provide Context Around Open Payments Data About PhRMA The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research and biotechnology companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives.
https://www.phrma.org/press-release/phrma-statement-on-the-sunshine-act-and-the-public-release-of-the-open-payments-database

Improved Adherence and Older Americans

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/improved-adherence-and-older-americans

Biopharmaceutical companies reaffirm commitment to patients in updated Principles on Conduct of Clinical Trials and Communication of Clinical Trial Results

PhRMA  |  Blog Post

Without clinical research studies, new medicines could not be approved by FDA and made available to the patients who need them.
http://catalyst.phrma.org/biopharmaceutical-companies-reaffirm-commitment-to-patients-in-updated-principles-on-conduct-of-clinical-trials-and-communication-of-clinical-trial-results

Record Number of New Medicines for Heart Disease and Stroke Now in Development

PhRMA  |  Press Release

Many of the potential medicines use cutting-edge technologies and new approaches such as one that uses human stem cells to form new heart muscle and restore cardiac functioning, and another that is a gene therapy that uses a patient’s own cells to treat heart failure.
https://www.phrma.org/press-release/record-number-of-new-medicines-for-heart-disease-and-stroke-now-in-development

EFPIA-PhRMA Principles successfully enable responsible clinical trial data sharing

PhRMA  |  Blog Post

Significantly, the survey results also demonstrate that the Principles established by PhRMA and EFPIA successfully enable responsible clinical trial data sharing, and are therefore well suited for use as others look to enhance data sharing practices and develop guiding principles.
http://catalyst.phrma.org/efpia-phrma-principles-successfully-enable-responsible-clinical-trial-data-sharing

Responsible Clinical Trial Data Sharing Is Enhancing Science and Improving Patient Health

PhRMA  |  Blog Post

 Key aspects of the principles include: Patient-level clinical trial data, study-level clinical trial data, full clinical study reports, and protocols from clinical trials in patients for medicines approved in the United States and European Union will be shared with qualified scientific and medical researchers upon request and subject to terms necessary to protect patient privacy and confidential commercial information.
http://catalyst.phrma.org/responsible-clinical-trial-data-sharing-is-enhancing-science-and-improving-patient-health

Testimony of Lori M. Reilly Before the Senate Health, Education, Labor and Pensions Committee

PhRMA  |  Speeches & Communication

Reilly, executive vice president, policy, research, and membership at PhRMA, before the Senate Health, Education, Labor and Pensions Committee on October 17, 2017.
https://www.phrma.org

India and Intellectual Property

PhRMA  |  Press Release

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research and biotechnology companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives.
https://www.phrma.org/press-release/india-and-intellectual-property

PhRMA Convenes Stakeholders to Discuss Value Assessments and New Ways to Pay for Medicines

PhRMA  |  Press Release

About PhRMA The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier and more productive lives.
https://www.phrma.org

Nearly 300 Medicines in Development to Treat Two Leading Causes of Death

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.3 billion in 2009.
https://www.phrma.org/press-release/nearly-300-medicines-in-development-to-treat-two-leading-causes-of-death

Local Impact: Hepatitis C and Medicaid spending

PhRMA  |  Blog Post

Advances such as these exemplify the integral role that medicines play in not only helping patients live healthier, more productive lives, but also preventing economic burdens and relieving stress on the health care system.
http://catalyst.phrma.org/local-impact-hepatitis-c-and-medicaid-spending

Closing the Gap: Increasing Global Competition to Attract and Grow the Biopharmaceutical Sector

PhRMA  |  Report

The biopharmaceutical industry’s economic benefit in the United States is amplified by its large-scale supply chain for research and development (R&D), manufacturing, and distribution activities.
https://www.phrma.org

Biopharmaceutical Leaders: Japanese Patients, Health Care System and Economy Benefit from Access to Innovative Medicines

PhRMA  |  Press Release

Eli Lilly and Company chairman and CEO David A.
https://www.phrma.org

PhRMA Statement on Presidential Commission on the Opioid Abuse Epidemic

PhRMA  |  Press Release

About PhRMA The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier and more productive lives.
https://www.phrma.org/press-release/phrma-statement-on-presidential-commission-on-the-opioid-abuse-epidemic

PhRMA and BIO Initiate Litigation to Challenge Unconstitutional Provisions of Nevada’s SB 539

PhRMA  |  Press Release

BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products.
https://www.phrma.org/phrma-bio-release

The Lengthy, Costly, and Uncertain Biopharmaceutical Research and Development Process

Chartpack  |  From Our Network

From drug discovery through FDA approval, developing a new medicine on average takes 10 years and an estimated $2.6 billion.
http://chartpack.phrma.org/2016-perspective/chapter-2/the-lengthy-costly-and-uncertain-biopharmaceutical-research-and-development-process

Fighting Leukemia and Lymphoma

From Hope To Cures  |  From Our Network

More Than 240 Medicines in Development for Leukemia, Lymphoma and Other Blood Cancers
http://www.fromhopetocures.org/fighting-leukemia-and-lymphoma

Medicare Monday: Part D then and now

PhRMA  |  Blog Post

Tune in next week for our next Part D Then and Now.
http://catalyst.phrma.org/medicare-monday-part-d-then-and-now

340B: Past and Present

Chartpack  |  From Our Network

When it was created in 1992, 340B was envisioned as a small program however insufficient guidance, historically weak oversight, and other factors have led to dramatic program growth, driven by the participation of large hospitals in the 340B program.
http://chartpack.phrma.org/programs-chartpack/medicines-in-340b/340b-past-and-present

You have reviewed the first 125 results out of 2501. Each page contains 25 results. You're on page 5.

prev 1 2 3 4 5 6 next